Know Cancer

or
forgot password

A Randomized Controlled Trial of Endobronchial or Endoscopic Ultrasound as a First Test in the Diagnosis and Staging of Lung Cancer


Phase 3
18 Years
N/A
Open (Enrolling)
Both
Bronchogenic Carcinoma

Thank you

Trial Information

A Randomized Controlled Trial of Endobronchial or Endoscopic Ultrasound as a First Test in the Diagnosis and Staging of Lung Cancer


Inclusion Criteria:



- Consecutive patients suspected of lung cancer on CT scan

- Written informed consent

- Able to tolerate bronchoscopy and thoracic surgery

Exclusion Criteria:

- Evidence of severe or uncontrolled systemic disease that makes it undesirable for the
patient to participate in the trial

- Any disorder making reliable informed consent impossible

- Patients with extra-thoracic disease, supraclavicular lymphadenopathy or pleural
effusion

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Time from first outpatient appointment to decision to treat

Outcome Time Frame:

1 - 3 months

Safety Issue:

No

Principal Investigator

Stephen Spiro, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Univeristy College London NHS Trust

Authority:

United Kingdom: Research Ethics Committee

Study ID:

07/0156

NCT ID:

NCT00652769

Start Date:

March 2008

Completion Date:

July 2012

Related Keywords:

  • Bronchogenic Carcinoma
  • Lung
  • Cancer
  • Staging
  • Endobronchial
  • Ultrasound
  • Endoscopic
  • Carcinoma
  • Carcinoma, Bronchogenic
  • Lung Neoplasms

Name

Location